Neurodegeneration with Brain Iron Accumulation: Diagnosis and Management

Overview

Journal J Mov Disord

Date 2015 Jan 24

PMID 25614780

Citations 71

Authors

Penelope Hogarth

Affiliations

Soon will be listed here.

Abstract

Neurodegeneration with brain iron accumulation (NBIA) encompasses a group of inherited disorders that share the clinical features of an extrapyramidal movement disorder accompanied by varying degrees of intellectual disability and abnormal iron deposition in the basal ganglia. The genetic basis of ten forms of NBIA is now known. The clinical features of NBIA range from rapid global neurodevelopmental regression in infancy to mild parkinsonism with minimal cognitive impairment in adulthood, with wide variation seen between and within the specific NBIA sub-type. This review describes the clinical presentations, imaging findings, pathologic features, and treatment considerations for this heterogeneous group of disorders.

Citing Articles

Syndromic Retinitis Pigmentosa: A Narrative Review.

Janaky M, Braunitzer G Vision (Basel). 2025; 9(1.

PMID: 39846623 PMC: 11755594. DOI: 10.3390/vision9010007.

Postencephalitic Parkinsonism: Unique Pathological and Clinical Features-Preliminary Data.

Strobel S, Sian-Hulsmann J, Tappe D, Jellinger K, Riederer P, Monoranu C Cells. 2024; 13(18.

PMID: 39329695 PMC: 11430219. DOI: 10.3390/cells13181511.

Genetic Targets and Applications of Iron Chelators for Neurodegeneration with Brain Iron Accumulation.

Marupudi N, Xiong M ACS Bio Med Chem Au. 2024; 4(3):119-130.

PMID: 38911909 PMC: 11191567. DOI: 10.1021/acsbiomedchemau.3c00066.

Trace Elements in Alzheimer's Disease and Dementia: The Current State of Knowledge.

Tyczynska M, Gedek M, Brachet A, Strek W, Flieger J, Teresinski G J Clin Med. 2024; 13(8).

PMID: 38673657 PMC: 11050856. DOI: 10.3390/jcm13082381.

Genetic aspects of ataxias in a cohort of Turkish patients.

Gogus B, Elmas M, Turk Boru U Neurol Sci. 2024; 45(9):4349-4365.

PMID: 38587696 PMC: 11306380. DOI: 10.1007/s10072-024-07484-x.

References

Dusi S, Valletta L, Haack T, Tsuchiya Y, Venco P, Pasqualato S . Exome sequence reveals mutations in CoA synthase as a cause of neurodegeneration with brain iron accumulation. Am J Hum Genet. 2013; 94(1):11-22. PMC: 3882905. DOI: 10.1016/j.ajhg.2013.11.008. View

Santoro L, Breedveld G, Manganelli F, Iodice R, Pisciotta C, Nolano M . Novel ATP13A2 (PARK9) homozygous mutation in a family with marked phenotype variability. Neurogenetics. 2010; 12(1):33-9. PMC: 3029807. DOI: 10.1007/s10048-010-0259-0. View

Zhang P, Gao Z, Jiang Y, Wang J, Zhang F, Wang S . Follow-up study of 25 Chinese children with PLA2G6-associated neurodegeneration. Eur J Neurol. 2012; 20(2):322-30. DOI: 10.1111/j.1468-1331.2012.03856.x. View

Fasano A, Ricciardi L, Bentivoglio A, Canavese C, Zorzi G, Petrovic I . Status dystonicus: predictors of outcome and progression patterns of underlying disease. Mov Disord. 2012; 27(6):783-8. DOI: 10.1002/mds.24981. View

Kruer M, Paisan-Ruiz C, Boddaert N, Yoon M, Hama H, Gregory A . Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA). Ann Neurol. 2010; 68(5):611-8. PMC: 6059612. DOI: 10.1002/ana.22122. View

Bruggemann N, Hagenah J, Reetz K, Schmidt A, Kasten M, Buchmann I . Recessively inherited parkinsonism: effect of ATP13A2 mutations on the clinical and neuroimaging phenotype. Arch Neurol. 2010; 67(11):1357-63. DOI: 10.1001/archneurol.2010.281. View

Ramirez A, Heimbach A, Grundemann J, Stiller B, Hampshire D, Cid L . Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet. 2006; 38(10):1184-91. DOI: 10.1038/ng1884. View

Deschauer M, Gaul C, Behrmann C, Prokisch H, Zierz S, Haack T . C19orf12 mutations in neurodegeneration with brain iron accumulation mimicking juvenile amyotrophic lateral sclerosis. J Neurol. 2012; 259(11):2434-9. DOI: 10.1007/s00415-012-6521-7. View

Al-Semari A, Bohlega S . Autosomal-recessive syndrome with alopecia, hypogonadism, progressive extra-pyramidal disorder, white matter disease, sensory neural deafness, diabetes mellitus, and low IGF1. Am J Med Genet A. 2006; 143A(2):149-60. DOI: 10.1002/ajmg.a.31497. View

10.

Edvardson S, Hama H, Shaag A, Gomori J, Berger I, Soffer D . Mutations in the fatty acid 2-hydroxylase gene are associated with leukodystrophy with spastic paraparesis and dystonia. Am J Hum Genet. 2008; 83(5):643-8. PMC: 2668027. DOI: 10.1016/j.ajhg.2008.10.010. View

11.

Saitsu H, Nishimura T, Muramatsu K, Kodera H, Kumada S, Sugai K . De novo mutations in the autophagy gene WDR45 cause static encephalopathy of childhood with neurodegeneration in adulthood. Nat Genet. 2013; 45(4):445-9, 449e1. DOI: 10.1038/ng.2562. View

12.

Allen N, Lin J, Lynch T, King M . Status dystonicus: a practice guide. Dev Med Child Neurol. 2013; 56(2):105-12. DOI: 10.1111/dmcn.12339. View

13.

Strokin M, Seburn K, Cox G, Martens K, Reiser G . Severe disturbance in the Ca2+ signaling in astrocytes from mouse models of human infantile neuroaxonal dystrophy with mutated Pla2g6. Hum Mol Genet. 2012; 21(12):2807-14. PMC: 3363330. DOI: 10.1093/hmg/dds108. View

14.

Crosiers D, Ceulemans B, Meeus B, Nuytemans K, Pals P, Van Broeckhoven C . Juvenile dystonia-parkinsonism and dementia caused by a novel ATP13A2 frameshift mutation. Parkinsonism Relat Disord. 2010; 17(2):135-8. DOI: 10.1016/j.parkreldis.2010.10.011. View

15.

Schottmann G, Stenzel W, Lutzkendorf S, Schuelke M, Knierim E . A novel frameshift mutation of C19ORF12 causes NBIA4 with cerebellar atrophy and manifests with severe peripheral motor axonal neuropathy. Clin Genet. 2013; 85(3):290-2. DOI: 10.1111/cge.12137. View

16.

Nardocci N, Zorzi G, Farina L, Binelli S, Scaioli W, Ciano C . Infantile neuroaxonal dystrophy: clinical spectrum and diagnostic criteria. Neurology. 1999; 52(7):1472-8. DOI: 10.1212/wnl.52.7.1472. View

17.

Koshy G, Danda S, Thomas N, Mathews V, Viswanathan V . Three siblings with Woodhouse-Sakati syndrome in an Indian family. Clin Dysmorphol. 2007; 17(1):57-60. DOI: 10.1097/MCD.0b013e3282beb59e. View

18.

Cheon Y, Kim H, Igarashi M, Modi H, Chang L, Ma K . Disturbed brain phospholipid and docosahexaenoic acid metabolism in calcium-independent phospholipase A(2)-VIA (iPLA(2)β)-knockout mice. Biochim Biophys Acta. 2012; 1821(9):1278-86. PMC: 3393806. DOI: 10.1016/j.bbalip.2012.02.003. View

19.

Wriekat A, Mubaidin A, Dasouki M, Hiari M . Pallido-pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor-Rakeb syndrome. Acta Neurol Scand. 1994; 89(5):347-52. DOI: 10.1111/j.1600-0404.1994.tb02645.x. View

20.

Strecker K, Hesse S, Wegner F, Sabri O, Schwarz J, Schneider J . Eye of the tiger sign in multiple system atrophy. Eur J Neurol. 2007; 14(11):e1-2. DOI: 10.1111/j.1468-1331.2007.01925.x. View